Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-24

Clinical Trial Update: Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas [Phase 2]

View source ↗

Summary

Phase 2 trial comparing propranolol to prednisolone for symptomatic infantile hemangiomas was terminated. Results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prednisolone (Prednisolone)
  • Propranolol (propranolol)

Snippet

Sponsor: Nancy Bauman | Conditions: Hemangioma of Infancy | Phase 2 | Status: TERMINATED | Results posted: 2016-02-24